The Prostate Cancer Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Prostate Cancer Therapeutics Market?
The market size of prostate cancer therapeutics has seen substantial growth recently. It is projected to increase from $11.92 billion in 2024 to $13.00 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 9.0%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Prostate Cancer Therapeutics Industry?
The Prostate Cancer Therapeutics Global Market Report 2025 predicts that by 2029, the market size will reach $18.16 billion, growing at a compound annual growth rate (CAGR) of 8.7%.
Download Your Free Sample of the 2025 Prostate Cancer Therapeutics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Prostate Cancer Therapeutics Market?
The key drivers in the prostate cancer therapeutics market are:
• Rising healthcare expenditure in emerging economies
• Growing investments in oncology drugs
• Increasing availability of advanced imaging and diagnostic tools
• Rising adoption of minimally invasive and non-surgical treatments
Global Market Segmentation: Identifying Major Prostate Cancer Therapeutics Industry Segments
The prostate cancer therapeutics market covered in this report is segmented –
1) By Therapy: Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, Other Therapies
2) By Drug Class: Androgen Receptor Inhibitors, GnRH Receptor Antagonists, PARP Inhibitors, Immune Checkpoint Inhibitors, Other Drug Classes
3) By Route Of Administration: Oral, Injectable
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Sales
5) By End User: Clinics, Hospitals, Other End Users
Pre-order the 2025 Prostate Cancer Therapeutics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Prostate Cancer Therapeutics Market?
The key trends in the prostate cancer therapeutics market are:
• Advancements in targeted cancer therapies are forging the future of the market.
• The integration of precision cancer medicine is an emerging trend.
• Development of technology-oriented diagnostic imaging tools is shaping the market.
• The market is witnessing advancements in immunotherapy for prostate cancer.
Who Are the Top Competitors & Leading Players in the Prostate Cancer Therapeutics Market?
Major players in the prostate cancer therapeutics market are:
• Johnson & Johnson
• Merck & Co. Inc.
• AbbVie Inc.
• Novartis AG
• AstraZeneca plc
• Sanofi S.A.
• Astellas Pharma Inc.
• Jiangsu Hengrui Medicine Co. Ltd.
• Telix Pharmaceuticals
• Bayer AG
• Curium Pharma SAS
• Dendreon Pharmaceuticals
• Myovant Sciences GmbH
• Clovis Oncology Inc.
• Ipsen S.A.
• Veru Inc.
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche Ltd
• Dendreon Pharmaceuticals LLC
• Pfizer Inc.
• Fusion Pharmaceuticals Inc.
• Ferring B.V.
• Tolmar Pharmaceuticals Inc.
Regional Dominance: Which Area Leads the Global Prostate Cancer Therapeutics Market?
North America was the largest region in the prostate cancer therapeutics market in 2024
